Vaccine manufacturers in India and other third world country underdeveloped countries may be able to produce a lower-cost HPV vaccine in spite of the intricate array of patent protections on the technology, say researchers at the Duke fixture for Genome science of matter
notes:exact sciences are physics & Policy. At a cost of at least $300 for the three-dose regimen, the blockbuster HPV vaccines, including Gardasil- from Merck and Cervarix- from GlaxoSmithKline, are some of the most expensive ever introduced.

More: - The rest...